Natalizumab Treatment for Multiple Sclerosis: Middle East and North Africa Regional Recommendations for Patient Selection And Monitoring

R. Alroughani, H. Aref, S. Bohlega, I. A. Sherooqi, M. Dahdaleh, I. Feki, M. A. Jumah, M. Al-Kawi, S. Koussa, B. Yamout, Egypt, Saudi Arabia, Jordan, Tunisia, Lebanon, Iran, Kuwait